00:00 Cold Open: Lilly vs Novo Shock Timing Dave opens with the bombshell that Novo funded a tirzepatide trial while simultaneously announcing major price cuts to Wegovy and Ozempic, setting up a strategic chess match
Our study included these subgroups and found a higher risk of psychiatric outcomes with semaglutide use
The Phase 3 program is called TRIUMPH, running across obesity, osteoarthritis pain, cardiovascular outcomes, chronic low back pain, MASLD (formerly NAFLD), type 2 diabetes, and more
Here's what we learned about five claims you might be hearing about microdosing GLP-1s: Myth #1: Microdoses Are Simply Smaller Doses of FDA-Approved GLP-1 Drugs FDA-approved GLP-1 medications come in prepackaged and prefilled syringes each syringe contains one prescribed dose
Not a character flaw, Dr
Norepinephrine (NE) has been reported to promote iron uptake in vitro, leading to the growth of E